Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 5 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Monte Rosa Therapeutics Inc have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 11.00. The median estimate represents a 156.00% increase from the last price of 6.25.
High | 220.0% | 20.00 |
Med | 156.0% | 16.00 |
Low | 76.0% | 11.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 11, 2024.
Average growth rate | +11.51% |
Average growth rate | +3.97% |
More ▼
Revenue history & estimates in USD
Average growth rate | +113.75% |
Average growth rate | 0.00% |
More ▼